Evaluating Virginia’s opioid treatment centers for certification

The Challenge 

In order to address the opioid epidemic within the state, the Commonwealth of Virginia is implementing a Medicaid 1115 Demonstration waiver to improve access to treatment for opioids and other addictive substances.

Westat was selected by the Commonwealth’s Medicaid agency to assist it by certifying residential substance use treatment programs according to the criteria of the American Society of Addiction Medicine (ASAM). The ASAM Level 3 Residential provider certification is required to enable the treatment programs to participate in Virginia’s regional Medicaid managed care programs.

Our Solutions 

  • Westat sent teams of experienced senior substance use treatment clinicians and program managers to conduct on-site surveys of approximately 85 Virginia Addiction Recovery and Treatment Services Program (ARTS) provider applicants for the 4 different Level 3 certification categories (transitional group homes; group homes; residential treatment centers; and residential, crisis, and inpatient detoxification).
  • After each on-site survey and review, Westat issued a notification report with 1 of 3 outcomes: full certification, certification pending submittal of a Plan of Correction, or denial of application.
  • We completed this evaluation within a 4-month period and with a high level of satisfaction from Virginia’s Department of Medical Assistance Services and the provider agencies.

The Results 

  • Strategies like these are a frontline effort to ensure a robust response to the opioid epidemic and improve the health and well-being of Virginia’s residents.

Our Client 

Virginia Department of Medical Assistance Services (DMAS)